SB
ARKG icon

Strategic Blueprint’s ARK Genomic Revolution ETF ARKG Stock Holding History

Strategic Blueprint’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,720
Closed -$252K – 672
2024
Q4 		$252K Sell
10,720
-3,440
-24% -$84.7K 0.02% 569
2024
Q3 		$362K Sell
14,160
-2,431
-15% -$61.9K 0.02% 475
2024
Q2 		$390K Sell
16,591
-2,302
-12% -$58.1K 0.03% 434
2024
Q1 		$543K Sell
18,893
-2,586
-12% -$77.8K 0.04% 364
2023
Q4 		$705K Sell
21,479
-2,148
-9% -$58.4K 0.06% 286
2023
Q3 		$658K Buy
23,627
+1,445
+7% +$47.2K 0.06% 285
2023
Q2 		$756K Sell
22,182
-476
-2% -$15K 0.07% 240
2023
Q1 		$681K Buy
22,658
+1,909
+9% +$59.2K 0.07% 249
2022
Q4 		$586K Buy
20,749
+742
+4% +$23.5K 0.07% 265
2022
Q3 		$658K Buy
20,007
+3,716
+23% +$136K 0.08% 239
2022
Q2 		$513K Sell
16,291
-1,230
-7% -$43K 0.06% 270
2022
Q1 		$805K Buy
17,521
+5,293
+43% +$252K 0.09% 210
2021
Q4 		$749K Buy
12,228
+4,486
+58% +$310K 0.09% 204
2021
Q3 		$578K Buy
7,742
+2,856
+58% +$240K 0.09% 212
2021
Q2 		$452K Buy
4,886
+893
+22% +$75.9K 0.07% 245
2021
Q1 		$354K Buy
+3,993
New +$396K 0.08% 217

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Strategic Blueprint's ARKG Position: Q1 2025 in Review

Strategic Blueprint sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 10,720 shares — an estimated $252K sold.

Strategic Blueprint first reported a position in ARKG in Q1 2021 and held it in 16 quarters. The position peaked at $805K in Q1 2022. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • Strategic Blueprint reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • Strategic Blueprint sold 10,720 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $252K.
  • Strategic Blueprint first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 16 quarters.
  • Strategic Blueprint's ARK Genomic Revolution ETF position peaked at $805K in Q1 2022.
  • 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Strategic Blueprint's 13F filing for Q1 2025, filed 29 Apr 2025.